Reading: Wastewater Testing and Community Drug Monitoring

On May 4, 2026 the White House added a plan to implement wastewater testing at national scale to the National Drug Control Strategy. The move aims to produce near real-time data about illegal drug use across communities. The policy has been presented as a way to modernize public health data systems and guide interventions.

Wastewater-based epidemiology is an established method that measures drug residues and metabolites in sewage to estimate community drug use. Laboratories analyze samples using advanced instruments such as liquid chromatography and mass spectrometry, and results are normalized by wastewater flow and by population to estimate consumption. Although these measurements give useful trends, they produce aggregate estimates and are not intended to identify individuals.

However, experts and ethicists have warned that expanded wastewater testing raises group privacy and stigma risks, especially if sampling is done at small scales like a single building or neighborhood. The National Academies and ethics studies have recommended oversight, transparency, and limits on law enforcement access to protect communities. Therefore privacy safeguards and clear rules will be important as cities and agencies roll out broader testing.